A

Alia Therapeutics

10 employees

Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2018

Funding rounds raised

Total raised

$4.8M

from 5 investors over 5 rounds

A

Alia Therapeutics raised $4.8M on April 17, 2023

Investors: BiovelocITA, Indaco Venture Partners and Sofinnova Partners

A

Alia Therapeutics raised undisclosed on June 30, 2021

Investors: Sofinnova Partners

A

Alia Therapeutics raised $1.5M on April 8, 2019

Investors: Trentino Invest

FAQ